A role for reactive oxygen species in the pathogenesis of focal glomerulosclerosis

Japanese Journal of Nephrology

Volumn 38, Issue 11, 1996, Pages 484-492

  Kawamoto, Shinya ^a   Kawamura, Tetsuya ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

deferoxamine (DFO); focal segmental glomerulosclerosis (FSGS); glomerular macrophage; puromycin aminonucleoside (PAN); reactive oxygen species (ROS)

Indexed keywords

DEFEROXAMINE; PUROMYCIN AMINONUCLEOSIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY FUNCTION; NONHUMAN; PATHOGENESIS; PROTEINURIA; RAT;

ANIMALS; DEFEROXAMINE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; MACROPHAGES; MALE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 0029805411     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Diamond JR: Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. (Editional review), Kidney Int 33: 917-924, 1988
2. Saito T, Atkins RC: Contribution of mononuclear leucocytes to the progression of experimental focal glomerular sclerosis. Kidney Int 37: 1076-1083, 1990
3. Diamond JR, Karanovsky MJ: Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside. Am J Pathol 122:481-487, 1986
4. Anderson S, Diamond JR, Karanovsky MJ, Brenner BM: Mechanism underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 82: 1757-1768, 1988
5. Grond J, Weening JJ, Elema JD: Glomerular sclerosis in nephrotic rats. Comparison of long-term effect of adriamycin and aminonucleoside. Lab Invest 51: 277-285, 1984
6. Diamond JR, Pesek DI: Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: role of macrophages. Am J Physiol 260: 779-786, 1991
7. Diamond JR, Pesek I, Ruggieri S, Karnovsky MJ: Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury. Am J Physiol 257: 798-807, 1991
8. Diamond JR, Ding G, Frye J, Pesek I: Glomerular macrophages and the mesangial proliferative response in the experimental nephrotic syndrome. Am J Patol 141: 887-894, 1992
9. Schreiner GF: The mesangial phagocyte and its regulation of contractile cell biology. J Am Soc Nephrol 2: (Suppl. 2,) s74-s82, 1992
10. Hirano T, Mamo JC, Onami K, Sugisaki T: Treatment of hyperlipidemia with probucol reduces proteinuria in puromycin aminonucleoside-induced nephrotic rats. Nephron 54: 358-359, 1990
11. Diamond JR, Bonventre JV, Karnovsky MJ: A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int 29: 478-483, 1986
12. Thakur VD, Walker PD, Shah SV: Evidence suggesting a role for hydroxy radical in puromycin aminonucleoside-induced proteinuria. Kidney Int 34: 494-499, 1988
13. Shah SV: Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35: 1093-1106, 1989
14. Rehan A, Johnson KJ, Wiggins RC, Kunkel RG, Ward PA: Evidence for the role of oxygen radicals in acute nephrotoxic nephritis. Lab Invest 51: 396-403, 1984
15. Trachtman H, Pizzo RD, Futterweit S, Levine D, Rao PS, Valderrama E, Sturman JA: Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. Am J. Physiol 262: F117-123, 1992
16. Hoyer JR, Ratte J, Potter AH, Michael AF: Transfer of aminonucleoside nephrosis by renal transplantation. J Clin Invest 51: 2777-2780, 1972
17. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362: 801-809, 1993
18. Cybulsky MI, Gimbrone MA Jr: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251: 788-791, 1991.
19. Li, H, Cybulsky MI, Gimbrone MA Jr., Libby P: An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 13: 197-204, 1993.
20. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR: Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 140: 665-673, 1992.
21. Tanaka H, Sukhova GK, Swanson SJ, Clinton SK, Ganz P, Cybulsky MI, Libby P: Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 88: 1788-1803, 1992.
22. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexaden RW, Medford RM: Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92: 1866-1874, 1993.
23. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A 87: 5134-5138, 1990
24. Dal Canton A, Fuiano G, Sepe V, Caglioti A, Ferrone S: Mesangial expression of intercellular adhesion molecule-1 in primary glomerulosclerosis. Kidney Int 41: 951-955, 1992
25. Radeke HH, Meier B, Topley N, Floge J, Habermehl GG, Resch K: Interleukin 1-α and tumor necrosis fact or-α induces oxygen radical production in mesangial cells. Kidney Int 37: 767-775, 1990
26. Utsunomiya Y, Abe A, Takahashi T, Imasawa T, Sakai T, Kawamura T, Mitarai T, Sakai O: The role of interaction between glomerular macrophages and mesangial cells in the progression of IgA nephropathy. J Am Soc Nephrol (in press)